Purification method of abiraterone
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 成都伊诺达博医药科技有限公司
- Publication Date
- 2012-12-12
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of pharmaceutical synthesis technology, and in particular relates to a purification method of abiraterone. Background technique
[0002] Prostate cancer is a malignant tumor that occurs in male prostate tissue and is the result of abnormal and disordered growth of prostate acinar cells. Prostate cancer incidence varies markedly by geographic and ethnic origin. In developed countries and regions such as Europe and the United States, it is the most common malignant tumor in men, and its mortality rate ranks second among various cancers; in Asia, its incidence rate is lower than that in Western countries, but it has shown a rapid upward trend in recent years. Studies have found that the male hormone testosterone can stimulate the growth of prostate tumors, so clinical treatment generally uses drugs or surgery to reduce the production of testosterone or block the effect of testosterone. But it has been clinica...